These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3441445

  • 21. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H.
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [Abstract] [Full Text] [Related]

  • 22. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B, Gingerich RL, Havel PJ.
    Regul Pept; 1995 Nov 10; 59(3):297-302. PubMed ID: 8577934
    [Abstract] [Full Text] [Related]

  • 23. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini.
    Akiyama T, Otsuki M.
    Pancreas; 1994 May 10; 9(3):324-31. PubMed ID: 8022754
    [Abstract] [Full Text] [Related]

  • 24. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
    Murayama KM, Drew JB, Nahrwold DL, Joehl RJ.
    Pancreas; 1990 Jul 10; 5(4):439-44. PubMed ID: 1696383
    [Abstract] [Full Text] [Related]

  • 25. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy.
    Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV.
    Am J Physiol; 1997 Jun 10; 272(6 Pt 1):G1550-9. PubMed ID: 9227493
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T, Tachibana I, Hirohata Y, Shirohara H, Yamamoto M, Otsuki M.
    Br J Pharmacol; 1996 Apr 10; 117(7):1558-64. PubMed ID: 8730754
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of bombesin-induced pancreatic secretion in unanesthetized rats.
    Liehr RM, Reidelberger RD, Varga G, Solomon TE.
    Peptides; 1993 Apr 10; 14(4):717-23. PubMed ID: 8234015
    [Abstract] [Full Text] [Related]

  • 28. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG, Axelson J, Sternby B, Rehfeld J, Ihse I, Ekelund M.
    Scand J Gastroenterol; 1997 Apr 10; 32(4):380-6. PubMed ID: 9140162
    [Abstract] [Full Text] [Related]

  • 29. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS, Liang JP, Owyang C.
    Am J Physiol; 1988 Sep 10; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [Abstract] [Full Text] [Related]

  • 30. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC, Zhang L, Chiang HC, Wank SA, Maton PN, Gardner JD, Jensen RT.
    Am J Physiol; 1989 Jul 10; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [Abstract] [Full Text] [Related]

  • 31. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A, Jaworek J, Konturek PK, Konturek SJ, Warzecha Z.
    J Physiol; 1989 Apr 10; 411():419-35. PubMed ID: 2614728
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Role of CCK in the regulation of secretion and adaptation in the pig pancreas.
    Lhoste EF, Gueugneau AM, Garofano A, Philippe C, Levenez F, Corring T.
    Pancreas; 1995 Jul 10; 11(1):86-94. PubMed ID: 7667247
    [Abstract] [Full Text] [Related]

  • 34. CCK receptors in release of pancreatic polypeptide (PP) in dogs.
    Konturek SJ, Konturek P, Bielański W, Szewczyk K.
    Dig Dis Sci; 1989 Jun 10; 34(6):849-56. PubMed ID: 2721318
    [Abstract] [Full Text] [Related]

  • 35. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L, Dockray GJ.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):307-11. PubMed ID: 3371402
    [Abstract] [Full Text] [Related]

  • 36. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG, Bendesky RJ, Schaffer L, Nolan TE, Gould RJ, Clineschmidt BV.
    J Pharmacol Exp Ther; 1987 Apr 09; 241(1):110-6. PubMed ID: 2437283
    [Abstract] [Full Text] [Related]

  • 37. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Gettys TW, Taylor IL, Rushakoff RJ, Williams VC, Coker LD.
    J Clin Endocrinol Metab; 1990 May 09; 70(5):1312-8. PubMed ID: 2186058
    [Abstract] [Full Text] [Related]

  • 38. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI, Manso MA, Garcia-Montero AC, Orfao A, de Dios I.
    Pancreas; 1997 Oct 09; 15(3):314-22. PubMed ID: 9336798
    [Abstract] [Full Text] [Related]

  • 39. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y, Hao Y, Owyang C.
    Am J Physiol; 1997 Sep 09; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [Abstract] [Full Text] [Related]

  • 40. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R, Schmidt WE, Lohmann C, Köhler H, Schlemminger R, Schafmayer A.
    Digestion; 1993 Sep 09; 54(2):79-83. PubMed ID: 8319843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.